2 high-yielding shares I’d buy and hold for a decade

With high dividend yields and stable business models, I think these FTSE 100 (INDEXFTSE:UKX) shares offer a great opportunity to buy, hold and make big gains.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Given the long-term success of investors such as Warren Buffett and Nick Train, the kind of buy-and-hold approach to investing they advocate is not one to be ignored. I’ve picked out two shares from the FTSE 100 that I’d be comfortable purchasing and holding for the next 10 years.

The chemicals giant

Croda (LSE: CRDA) has a yield of 6.23% – boosted by a special dividend this year – and its forward yield is the same percentage, so it certainly offers income investors a generous return. 

The investment case for the chemicals company looks compelling to me. It’s a global firm, selling in 38 counties and focusing on four massive markets: personal care, life sciences, performance technologies and industrial chemicals The model is capital-light, provides premium products and the company has a close relationship with its customers, which means it’s hard to replace.

The group achieves a return on capital employed (ROCE) of 18.2%, which I consider to be quite high, although the downside is the level has fallen for several years in a row. Nonetheless, this measurement demonstrates that it’s a well-run business.

Recent results also are testament to this view. Sales increased from £1.37bn in 2017 to £1.39bn in 2018, while adjusted profit before tax grew by 6.2% and the dividend by 7.4%.

The combination of acquisitions with capital expenditure on R&D and new manufacturing capabilities, I think, means Croda is well-positioned for the next decade.

Recovering ad men

WPP (LSE: WPP) is still reeling from the departure of Sir Martin Sorrell and the shares have halved from their five-year high, which was back in 2017. The lower share price does mean now that the shares have a dividend yield of 6.23%.

The business is going through a period of change that I think will position it well for investors prepared to jump in now and hold on to the shares. There have been 44 disposals over the last 15 months, which has simplified the group and given it the opportunity to focus on the US.

WPP is in the process of selling off a large part of its data, research and consulting company, Kantar. Some 60% is being sold to Bain capital in a deal to be approved by shareholders later this month. The deal values Kantar at $4bn and WPP will use some of the proceeds of the sale to reduce debt, while an estimated $1.2bn will be returned to shareholders.

The impact of change

Given the change within the business, it’s little surprise the first-half results weren’t pretty. Profit before tax was down 43.5% and operating margins fell slightly as well.

Commenting on the results, CEO Mark Read said: “When the Kantar transaction completes, our disposal programme will have generated proceeds of c.£3.6bn, allowing us to return significant amounts to shareholders and reduce our leverage to the low end of the target range.”

With shareholders set to be rewarded from disposals, reduced debt and more focus on growth areas, WPP should emerge stronger from its current restructuring – even if right now it means the financial results don’t look particularly encouraging.  

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Andy Ross has no position in any of the shares mentioned. The Motley Fool UK has recommended Croda International. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »